Home › Encyclopedia › Kisspeptin: Research Status and Trial Data
Research / Unapproved

Kisspeptin: Research Status and Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC258H401N79O78
Molecular weight5857 g/mol
Registered trials45
PubChem CID71306396

Key takeaways

  • Kisspeptin is an investigational compound with no approved drug label.
  • It has a large peptide structure, with a molecular formula of C258H401N79O78 and a molecular weight near 5,857.
  • At least 45 trials involving kisspeptin have been registered.
  • Sampled trials span pediatric endocrinology follow-up and neuropeptide stimulation research.
  • One sampled trial was terminated at an early phase, and other trials carry unknown status.

What kisspeptin is

Kisspeptin is a large peptide compound identified by PubChem CID 71306396. It has not been reviewed or approved by any regulatory agency, and no official drug label exists for it. Researchers are studying it as part of investigations into hormonal signaling pathways, though this description does not imply any confirmed benefit or approved use.

Trial footprint

Registries list 45 trials referencing kisspeptin. The available sample includes a follow-up study of girls with premature thelarche and precocious puberty, whose status is listed as unknown. Another sampled trial, examining neuropeptide stimulation through a recall-by-genotype design, reached phase 1 before being terminated. A third trial looked at LH response to a GnRH test in young prepubescent girls, also with unknown status. These examples reflect a mix of observational follow-up and early-phase mechanistic research rather than large confirmatory studies.

FAQ

Is kisspeptin an approved medication?
No. Kisspeptin has no approved drug label from any regulatory agency. It is currently studied only in a research context.
What is kisspeptin used for in research?
Registered trials have examined kisspeptin in areas like puberty-related hormone signaling and neuropeptide stimulation. These are investigational studies, and none confirm an approved therapeutic use.
How many clinical trials have studied kisspeptin?
Public registries list at least 45 trials that reference kisspeptin. Sampled examples include studies in pediatric endocrinology and early-phase neuropeptide research.
Did any kisspeptin trials report results on side effects?
The data available here does not include reported adverse event counts for kisspeptin. Any safety profile would need to come from the full trial results themselves.
What kind of molecule is kisspeptin?
Kisspeptin is a large peptide with the molecular formula C258H401N79O78 and a molecular weight of about 5,857. It is cataloged in PubChem under CID 71306396.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-03